Esparza-Garrido RR, Velazquez-Flores MA, Arenas- Aranda DJ, Salamanca-Gómez F

Idioma: Español
Referencias bibliográficas: 15
Paginas: 265-267
Archivo PDF: 35.22 Kb.

FRAGMENTO

Agradecemos al doctor Víctor Manuel Valdespino Gómez sus comentarios a nuestro artículo “La Genómica en la Medicina”.1 Como menciona el doctor Valdespino, el objetivo de nuestro artículo fue analizar de manera sencilla y didáctica los principales avances que se han producido en las últimas décadas en el estudio genómico de las enfermedades complejas como el cáncer.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ruiz R, Velázquez MA, Arenas D, Salamanca F. La genómica en la Medicina. Rev Med Inst Mex Seguro Soc. 2014; 52(5):566-73.

2. Cohen JP, Felix AE. Personalized Medicine’s Bottleneck: Diagnostic Test Evidence and Reimbursement. J Pers Med. 2014;4(2):163-75.

3. Bowdin S, Ray PN, Cohn RD, Meyn MS. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Hum Mutat. 2014;35(5):513-9.

4. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res. 2009;154(6):277-87.

5. Berkman BE, Hull SC, Eckstein L. The unintended implications of blurring the line between research and clinical care in a genomic age. Per Med. 2014;11(3):285-95.

6. Okimoto RA, Bivona TG. Recent advances in personalized lung cancer medicine. Per Med. 2014;11(3):309-21.

7. Jekunen A. Clinicians’ expectations for gene-driven cancer therapy. Clin Med Insights Oncol. 2014;8:159-64.

8. Liu M, Maurano MT, Wang H, Qi H, Song CZ, Navas PA, et al. Genomic discovery of potent chromatin insulators for human gene therapy. Nat Biotechnol. 2015 Jan 12. doi: 10.1038/ nbt.3062. [Epub ahead of print]

9. Le Du F, Ueno NT. Targeted therapies in triple-negative breast cancer: failure and future. Womens Health (Lond Engl). 2015;11(1):1-5.

10. Sugawara K, Koushima Y, Inao M, Nakayama N, Nagoshi S, Yakabi K, et al. Multicenter Prospective Study to Optimize the Effi cacy of Triple Therapy with Telaprevir in Patients with Genotype 1b HCV Infection According to an Algorithm Based on the Drug Adherence, IL28B Gene Allele and Viral Response: the AG & RGT Trial. Hepatol Res. 2015 Jan 9. doi: 10.1111/ hepr.12475. [Epub ahead of print]

11. DiGiusto DL. Stem Cell Gene Therapy for HIV: Strategies to Inhibit Viral Entry and Replication. Curr HIV/AIDS Rep. 2015 Jan 13. [Epub ahead of print]

12. 12.Smith SN, Paige C, Velazquez KT, Smith TP, Raja SN, Wilson SP, et al. Injury-specifi c promoters enhance herpes simplex virus mediated gene therapy for treating neuropathic pain in rodents. J Pain. 2015; 7. pii: S1526-5900.

13. Muthiah M, Che HL, Klash S, Jo J, Choi SY, Kim WJ, et al. Formulation of glutathione responsive anti-proliferative nanoparticles from thiolated Akt1 siRNA and disulfi de-crosslinked PEI for effi cient anti-cancer gene therapy. Colloids Surf B Biointerfaces. 2014; 126C:322-7.

14. 14.Ruiz Esparza-Garrido R, Velázquez-Flores MÁ, Diegopérez-Ramírez J, López-Aguilar E, Siordia-Reyes G, Hernández-Ortiz M, et al. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. J Proteomics. 2013;94:162-75.

15. Castle S. Britain Set to Approve Technique to Create Babies From 3 People. NY Times. Feb. 3, 2015.